HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paola Di Meglio Selected Research

galactaric acid (mucic acid)

10/2022Biomarkers of disease progression in people with psoriasis: a scoping review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paola Di Meglio Research Topics

Disease

22Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 09/2007
11Inflammation (Inflammations)
01/2021 - 07/2003
3Edema (Dropsy)
11/2005 - 07/2003
2Psoriatic Arthritis
10/2022 - 04/2013
2Infections
01/2021 - 11/2014
2Skin Diseases (Skin Disease)
01/2021 - 08/2014
1Type 2 Diabetes Mellitus (MODY)
10/2022
1Disease Progression
10/2022
1Necrosis
10/2022
1COVID-19
01/2021
1Neoplasms (Cancer)
07/2013
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2013
1Crohn Disease (Crohn's Disease)
09/2007
1Neointima
08/2006
1Vascular System Injuries
08/2006
1Myocardial Infarction
08/2006
1Shock
02/2006
1Sepsis (Septicemia)
02/2006

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
10/2017 - 02/2006
5Biomarkers (Surrogate Marker)IBA
10/2022 - 04/2013
5Interleukin-23 (Interleukin 23)IBA
10/2013 - 09/2007
4HLA-C Antigens (HLA-C)IBA
10/2022 - 03/2012
3CarrageenanIBA
11/2005 - 07/2003
2Interleukin-17 (Interleukin 17)IBA
10/2022 - 04/2014
2LipopolysaccharidesIBA
10/2022 - 02/2006
2InterleukinsIBA
10/2022 - 10/2017
2Adalimumab (Humira)FDA Link
12/2021 - 01/2021
2Interleukin-22 (IL-22)IBA
11/2014 - 04/2014
2Transcription Factors (Transcription Factor)IBA
06/2014 - 07/2003
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
06/2014 - 01/2013
2LigandsIBA
06/2014 - 09/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2014 - 02/2006
2Peptides (Polypeptides)IBA
03/2012 - 12/2010
1Carrier Proteins (Binding Protein)IBA
10/2022
1Macrophage Colony-Stimulating FactorIBA
10/2022
1IntegrinsIBA
10/2022
1Immunoglobulin G (IgG)IBA
10/2022
1galactaric acid (mucic acid)IBA
10/2022
1Kallikreins (Kallikrein)IBA
10/2022
1Interleukin-13IBA
10/2022
1Ustekinumab (CNTO 1275)FDA Link
10/2022
1HLA-B Antigens (HLA-B)IBA
10/2022
1TyramineIBA
10/2022
1Pharmaceutical PreparationsIBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2021
1Biological ProductsIBA
01/2021
1Interleukin-1 (Interleukin 1)IBA
11/2016
1Immunologic Factors (Immunomodulators)IBA
08/2014
16-formylindolo(3,2-b)carbazoleIBA
06/2014
1Imiquimod (Aldara)FDA LinkGeneric
06/2014
1Fatty Acids (Saturated Fatty Acids)IBA
07/2013
1AutoantigensIBA
05/2012
1Interleukin-10 (Interleukin 10)IBA
05/2012
1Phosphotransferases (Kinase)IBA
12/2010
1Interleukin-12 (IL 12)IBA
11/2010
1Tumor Necrosis Factor InhibitorsIBA
11/2010
1Interleukin-18 (Interleukin 18)IBA
08/2006
1AntigensIBA
02/2006
1EndotoxinsIBA
02/2006
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2005
1Glucose (Dextrose)FDA LinkGeneric
05/2005
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2005
1PPAR-gamma AgonistsIBA
05/2005
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
05/2005
1Rosiglitazone (Avandia)FDA Link
05/2005
1Mifepristone (RU 486)FDA Link
05/2005
1ciglitazoneIBA
05/2005
1Oxidants (Oxidizing Agents)IBA
02/2005
1sodium arsenite (sodium metaarsenite)IBA
02/2005
1Heat-Shock Proteins (Heat-Shock Protein)IBA
07/2003
1DNA (Deoxyribonucleic Acid)IBA
07/2003
1OligodeoxyribonucleotidesIBA
07/2003

Therapy/Procedure

6Therapeutics
01/2021 - 09/2011
2Biological Therapy
01/2021 - 01/2021